Adoptive Transfer of NY-ESO-1 TCR Engineered Peripheral Blood Mononuclear Cells (PBMC) and Peripheral Blood Stem Cells (PBSC) After a Myeloablative Conditioning Regimen, With Administration of Interleukin-2, in Patients With Advanced Malignancies
Investigator(s):
Theodore Scott Nowicki, M.D., Ph.D.;
Organization:
UCLA
NCT Number:
Disease Name:
Sarcoma/Solid Tumors
Disease Category:
Trial Phases:
Phase 1
Trial Status:
Recruiting
The science behind UCLA stem cell center’s clinical trial for metastatic sarcoma
Trial Contact:
Ignacio Baselga Carretero, Ph.D.
(310) 206-2090
IBaselga@mednet.ucla.edu
Theodore Scott Nowicki, M.D., Ph.D.
(310) 206-2090
TNowicki@mednet.ucla.edu
